FDA NDC Directory · JSON-LD · Markdown

CRYSVITA

NDC 42747-102 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameBurosumab
Labeler / ManufacturerKyowa Kirin, Inc.
Marketing categoryBiologic License Application · App BLA761068
Dosage form / routeINJECTION · SUBCUTANEOUS
Active ingredientsBUROSUMAB (10 mg/mL)
Marketing started20180418
Package count1

External sources

Source: openFDA. Public-domain (CC0).